Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet

被引:82
|
作者
Hayami, Tomohide [1 ]
Kato, Yoshiro [1 ]
Kamiya, Hideki [1 ]
Kondo, Masaki [1 ]
Naito, Ena [1 ]
Sugiura, Yukako [1 ]
Kojima, Chika [1 ]
Sato, Sami [1 ]
Yamada, Yuichiro [1 ]
Kasagi, Rina [1 ]
Ando, Toshihito [1 ]
Noda, Saeko [1 ]
Nakai, Hiromi [1 ]
Takada, Eriko [1 ]
Asano, Emi [1 ]
Motegi, Mikio [1 ]
Watarai, Atsuko [2 ]
Kato, Koichi [3 ]
Nakamura, Jiro [1 ]
机构
[1] Aichi Med Univ, Sch Med, Dept Internal Med, Div Diabet, Nagakute, Aichi 48011, Japan
[2] Chubu Rosai Hosp, Ctr Prevent Med, Nagoya, Aichi, Japan
[3] Aichi Gakuin Univ, Sch Pharm, Lab Med, Nagoya, Aichi 464, Japan
关键词
Ketoacidosis; Low-carbohydrate diet; Sodium-glucose cotransporter2 inhibitor; INSULIN SENSITIVITY; DAPAGLIFLOZIN;
D O I
10.1111/jdi.12330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present a case of a 32-year-old diabetic woman with Prader-Willi syndrome who developed severe ketoacidosis caused by a sodium-glucose cotransporter2 (SGLT2) inhibitor, a novel class of antihyperglycemic agents, during a strict low-carbohydrate diet. At admission, a serum glucose level of 191mg/dL was relatively low, though laboratory evaluations showed severe ketoacidosis. This is the first report of ketoacidosis caused by a SGLT2 inhibitor. It is necessary to not only pay attention when using a SGLT2 inhibitor in patients following a low-carbohydrate diet, but also to start a low-carbohydrate diet in patients treated with a SGLT2 inhibitor because of a high risk for developing ketoacidosis.
引用
收藏
页码:587 / 590
页数:4
相关论文
共 50 条
  • [41] Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy
    Meyer, Emily J.
    Mignone, Edward
    Hade, Anthony
    Thiruvenkatarajan, Venkatesan
    Bryant, Robert V.
    Jesudason, David
    DIABETES CARE, 2020, 43 (11) : E181 - E184
  • [42] Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin!
    Kamath, Sangita D.
    Kumar, Umesh
    Shrivastava, Vikki
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [43] Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter type 2 inhibitors
    de Val, intigo Isern
    Castillo, Hector Mercado
    Mele, Maria del Carmen Diaz
    MEDICINA CLINICA, 2024, 163 (02): : 101 - 102
  • [44] When Guidelines Fail: Euglycemic Diabetic Ketoacidosis After Bariatric Surgery in a Patient Taking a Sodium-Glucose Cotransporter-2 Inhibitor: A Case Report
    Lane, Sophia
    Paskar, David
    Hamed, Shatha
    Goffi, Alberto
    A & A PRACTICE, 2018, 11 (02): : 46 - 48
  • [45] Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report
    Cha, Beda M.
    Davoudi, Roland
    DiVita, Michael C.
    Fan, Ashley M.
    Kamath, Megan Y.
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (08) : 2636 - 2639
  • [46] Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice
    Atageldiyeva, Kuralay
    Fujita, Yukihiro
    Yanagimachi, Tsuyoshi
    Mizumoto, Katsutoshi
    Takeda, Yasutaka
    Honjo, Jun
    Takiyama, Yumi
    Abiko, Atsuko
    Makino, Yuichi
    Haneda, Masakazu
    PLOS ONE, 2016, 11 (06):
  • [47] Sodium-Glucose Cotransporter-2 Inhibitor-Related Diabetic Ketoacidosis: Accuracy Verification of Operational Definition
    Kang, Dong Yoon
    Kim, Hyunah
    Ko, SooJeong
    Kim, HyungMin
    Shinn, Jiwon
    Kang, Min-Gyu
    Byeon, Sun-Ju
    Choi, Jeong-Hee
    Shin, Soo-Yong
    Kim, Hun-Sung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (07)
  • [48] EUGLYCEMIC DIABETIC KETOACIDOSIS CAUSED BY A SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR AFTER CORONARY ARTERY BYPASS GRAFTING
    Kameda, Yuika
    Kato, Masanori
    Inoue, Bon
    Yamazaki, Shintaro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2423 - 2423
  • [49] Sodium-glucose Cotransporter-2 Inhibitors and Euglycaemic Diabetic Ketoacidosis in the Perioperative Period: Case Report
    Jhaveri, Urmita
    Vardesh, Deepak
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (08)
  • [50] Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter 2 Inhibitor Use in Two Patients Undergoing Pancreatectomy
    Pace, Devon J.
    Dukleska, Katerina
    Phillips, Samantha
    Gleason, Vanessa
    Yeo, Charles J.
    JOURNAL OF PANCREATIC CANCER, 2018, 4 (01): : 95 - 99